Merck and Eisai update on Two Phase 3 Trials Evaluating Keytruda plus Lenima for cell lung cancer
The companies will work with investigators to share the results with the scientific community
The companies will work with investigators to share the results with the scientific community
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial
To implement AI-enabled chest X-ray solution for TB & COVID-19 screening in Maharashtra through Unitaid funding
Ayushman Bhav a comprehensive nationwide healthcare initiative ensures saturation coverage of healthcare schemes, reaching every village and town
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
This study showed that patients taking 75mg of Olpasiran previously every 12 weeks presented a 40–50% reduction in LP(a)
The three-week travel campaign is aimed at spreading awareness about infertility and making Karnataka infertility-free
Subscribe To Our Newsletter & Stay Updated